Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607
Human Genetics01:28

Human Genetics

625
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
625
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

104
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
104
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

763
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
763
Neural Regulation01:37

Neural Regulation

39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current practice patterns among Indian neurologists in the Evaluation and management of Normal Pressure Hydrocephalus: A nationwide cross-sectional survey.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Epileptic-Dyskinetic Encephalopathy in Snijders Blok-Campeau Syndrome: Expanding the Phenotypic Spectrum.

Movement disorders clinical practice·2026
Same author

Atypical Phenotype of Marinesco-Sjögren Syndrome with Predominant Myopathy due to a Novel SIL1 Variant.

Annals of Indian Academy of Neurology·2026
Same author

Expanding the Phenotype: Myoclonus-Dystonia as a Novel Manifestation of 47 XXX Syndrome.

Journal of movement disorders·2026
Same author

Spontaneous Intracranial Hypotension: A Tertiary Care Experience.

Annals of Indian Academy of Neurology·2026
Same author

Progressive Myoclonic Epilepsies - A Pragmatic Review.

Neurology India·2026

Related Experiment Video

Updated: Jul 25, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.2K

Parkinson's disease - genetic cause.

Ajith Cherian1, Divya K P, Asish Vijayaraghavan

  • 1Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.

Current Opinion in Neurology
|June 27, 2023
PubMed
Summary
This summary is machine-generated.

Genetic mutations are responsible for 5-10% of Parkinson's disease cases, with recent discoveries highlighting new genes and pathways. Understanding these genetic factors is crucial for developing personalized medicine approaches.

More Related Videos

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.0K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.6K

Related Experiment Videos

Last Updated: Jul 25, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.2K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.0K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.6K

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Parkinson's disease (PD) genetics has seen significant advancements, with 5-10% of cases attributed to monogenic causes.
  • Known genetic factors include mutations in autosomal dominant (e.g., SNCA, LRRK2) and recessive genes (e.g., PRKN, PINK1, DJ-1).
  • Recent findings implicate novel genes like RIC3, linked to the cholinergic pathway, and others such as MAPT, TMEM230, LRP10, NUS1, and ARSA.

Approach:

  • Comprehensive review of current literature on Parkinson's disease genetics.
  • Analysis of identified gene mutations and their associated clinical presentations.
  • Discussion of challenges in validating novel genetic associations.

Key Points:

  • Mutations in genes like DNAJC6 can cause atypical parkinsonism.
  • X-linked parkinsonism presents early with diverse neurological symptoms and poor levodopa response.
  • The discovery of RIC3 mutations highlights the role of the cholinergic pathway in PD etiology.
  • Five new putative disease-causing genes (MAPT, TMEM230, LRP10, NUS1, ARSA) have been identified.

Conclusions:

  • Genetic discoveries in Parkinson's disease are advancing rapidly.
  • Validating new genes is challenging due to sparse and widespread affected families.
  • Future genetic insights will enhance disease prediction, prognostication, and the development of precision medicine for Parkinson's disease.